SOD1 mutation carriers show a trend toward better performance in ALS-specific cognitive scores compared to sporadic ALS and C9orf72seq carriers, with statistically significant differences observed only between SOD1 carriers and sporadic ALS patients. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.